Il cancro alla prostata 4a tappa

E Medicina - IL RUOLO DELLA RADIOTERAPIA NEL TRATTAMENTO DEL TUMORE ALLA PROSTATA

Vitaprost di cosa si tratta

Maroncelli, 40 Meldola FC Italy. Events and promotional activities calendar. Il cancro alla prostata 4a tappa version. The activities of the Laboratory of Biosciences can be grouped into two main areas:.

The two areas are mutually interdependent but maintain their organizational autonomy. Research projects are conceived and developed mainly intersectorally on the basis of the technical and scientific skills needed to perform the research. Each sector has its own Coordinator.

To facilitate this organization, the laboratory is made up of a large common area, shared by all operators, and different environments with highly specialized equipment and dedicated personnel.

These environments can be accessed by other laboratory il cancro alla prostata 4a tappa when use of the equipment is required for their research projects. The current orientation of pharmacological research is il cancro alla prostata 4a tappa on the use of drugs that act on specific biomolecular targets, and on their combination with conventional cytotoxic agents.

It is therefore essential to have diagnostic-analytical instruments capable of correctly determining the presence and functionality of such biomolecular targets within the tumor cell. Genetic Counselling: the determination of mutations linked to the risk of developing hereditary cancers for their primary prevention or early detection.

The service provides genetic counselling and il cancro alla prostata 4a tappa related molecular analyses to identify patients with a hereditary predisposition to cancer. Read more Molecular and cellular biology: the determination of both prognostic biomarkers and biomarkers that are predictive of response to clinical treatments. The service also determines molecular markers that are predictive of response to treatment.

The Biomolecular Diagnostics area is closely linked to research as its diagnostic activities are often the result of the latest research data and require continuous monitoring and updating. Moreover, the area constantly provides new ideas for research projects. This is why the diagnostic activities are performed by personnel who are also actively involved in research projects in other sectors. This connection permits a higher standard of analysis and a greater ease of implementation of new tests and new methodologies of investigation.

The Basic and Preclinical Experimental Research area is divided into specialized sectors with personnel who have acquired experience in specific research topics and have the know-how necessary for the development of il cancro alla prostata 4a tappa projects in these areas.

In particular, the laboratory is currently divided into the following areas:. Cell Biology Coordinator: Dr Sara Bravaccini The objective of this area is to characterize tumor il cancro alla prostata 4a tappa for the identification of diagnostic, prognostic and predictive markers and implement them into routine clinical practice to facilitate early diagnosis and optimize clinical-therapeutic pathways of patients.

Prognostic and Predictive Biomarkers Coordinator: Dr Paola Ulivi This area focuses on the identification il cancro alla prostata 4a tappa validation of tissue, circulating, diagnostic, prognostic and predictive biomarkers and their transferral to routine clinical practice as an aid to early diagnosis and optimization of clinical-therapeutic pathways.

Preclinical Onco-Hematology Coordinator: Dr Silvia Carloni This sector focuses on translational research projects relating to hematological malignancies.

Preclinical Urology Coordinator: Dr Valentina Casadio This sector focuses on translational research projects relating to urogenital tumors. Radiobiology and Preclinical Pharmacology Coordinator: Il cancro alla prostata 4a tappa Anna Tesei This sector focuses on a number of areas: development of new molecules with anticancer activity and of new systems based on drug delivery nanotechnology; identification and development of new preclinical models capable of evaluating the cytotoxic activity induced by new radiation treatments on tumor tissue, both alone and in combination with chemotherapy; isolation, cultivation and characterization of cancer stem cells from the primary tumor and from metastases to identify new biomarkers specific for these cells to use as targets for the design of new drugs.

Molecular profiles Coordinator: Dr Daniele Calistri This sector focuses on the identification of genetic and epigenetic markers linked to neoplastic transformation or to the risk of neoplastic transformation. It is divided into two areas:. The Biosciences Laboratory Bioscienze promotes innovation-based competitiveness of regional businesses, its aim to use the results obtained from advanced scientific research to enhance personalized healthcare.

Bioscience Laboratory Quality manager: Dott. Daniele Calistri Education manager: Dott. Francesco Fabbri Security and waste management manager: Dott. Daniele Calistri Equipment manager: Dott. Giulia Gallerani Dr Pietro Fici. Bioinformatics Dr Michela Tebaldi. Pathology Representative. Breast cancer Dr Sara Bravaccini. Hematological desease Dr Silvia Carloni.

Skin cancer Dr Chiara Arienti. Thoracic cancer Dr Paola Ulivi. Neurological cancer Dr Sara Pignatta. Uro-gynecological cancer Dr Valentina Casadio. Radiotherapy Dott. Gastrointestinal cancer Dott. Bone cancer and Rare tumor Dr Laura Mercatali. Download Bioscience Laboratory organization chart in pdf format italian only Go to Science Laboratory whole staff list. Mappa del sito Cerca Professionista.

Maroncelli, 40 Meldola FC Italy e-mail: info irst. Events calendar. News and events. Biosciences Laboratory. Italian version Director f. Biomolecular Diagnostics Area.

Basic and Preclinic Sperimental Research Area. In particular, the laboratory is currently divided into the following areas: Cell Biology. Epigenomics and risk profilesdealing with the study of new genetic and epigenetic markers in non-hereditary tumors. Genetic predispositionwhich studies new genetic markers associated with the risk of developing hereditary cancers.

Research activities are managed by a senior biologist with long-standing experience in coordinating research and biomolecular diagnostics areas. Innovation and accreditation.

Customers satisfaction analysis italian only. Customer claim form italian only. Organization chart. Biosciences Laboratory Italian version Director f. Fine contenuti.